SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-22-022351
Filing Date
2022-04-28
Accepted
2022-04-28 16:59:45
Documents
16
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K f10k2021a1_180lifescien.htm   iXBRL 10-K/A 48524
2 CERTIFICATION f10k2021a1ex31-1_180lifesci.htm EX-31.1 3145
3 CERTIFICATION f10k2021a1ex31-2_180lifesci.htm EX-31.2 3289
4 GRAPHIC image_001.jpg GRAPHIC 4408
  Complete submission text file 0001213900-22-022351.txt   296768

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE atnf-20211231.xsd EX-101.SCH 3285
6 XBRL DEFINITION FILE atnf-20211231_def.xml EX-101.DEF 17087
7 XBRL LABEL FILE atnf-20211231_lab.xml EX-101.LAB 36466
8 XBRL PRESENTATION FILE atnf-20211231_pre.xml EX-101.PRE 18146
10 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021a1_180lifescien_htm.xml XML 7700
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38105 | Film No.: 22867756
SIC: 2834 Pharmaceutical Preparations